Gut Microbe Takes a Share of Our Brain Meds

08:30 EDT 14 Jun 2019 | Genetic Engineering News

A human gut bacterium metabolizes levodopa, the primary drug treatment for Parkinson’s disease (PD). By identifying this bacterium, which happens to be Enterococcus faecalis, scientists based at Harvard University suggest why the efficacy of PD therapy seems to vary so much between individual patients. The scientists also demonstrated that the interfering bacterial pathway could be blocked by a small molecule drug called AFMT.

The post Gut Microbe Takes a Share of Our Brain Meds appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Gut Microbe Takes a Share of Our Brain Meds


More From BioPortfolio on "Gut Microbe Takes a Share of Our Brain Meds"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...